companies > M > Merck Merck & Co FDA bars use of Merck's cancer vaccine by women over 27 26 June 2008 Ranbaxy to develop new drugs for Merck & Co 10 May 2008 Merck extends enrollment deadline for US Vioxx product liability lawsuit claimants 03 May 2008 US FDA turns down Merck's ER niacin / laropiprant 29 April 2008 Shasun Chemicals technology licenses API technology to Merck 27 February 2008 Nicholas Piramal in R&D collaboration with Merck & Co 19 November 2007 Merck agrees to settle Vioxx claims for $4.85 billion 15 November 2007 Merck buys cardiac biotech start-up NovaCardia 31 July 2007 Merck to acquire NovaCardia for $350 million 27 July 2007 Court revives shareholder lawsuits over Vioxx against Merck 20 July 2007 Ranbaxy withdraws bid for Merck's generic business 20 March 2007 Ranbaxy enters second round of bidding for Merck unit: report 16 March 2007 Merck suffers adverse Vioxx lawsuit in the US 13 March 2007 Dr Reddy's to join the race for Merck's generic business 05 February 2007 Ranbaxy to bid over $5 billion for Merck Generics 09 January 2007 Tata Group''s Advinus to develop metabolic drugs for Merck 16 November 2006 Merck & Co develops new diabetes drug 14 June 2006 Merck wins second Vioxx lawsuit 18 February 2006 Merck allows Dr Reddy's to sell authorised generics of blockbuster drugs 02 February 2006 Dr Reddy's Laboratories enters into agreement with Merck 01 February 2006 Merck, ICMR to conduct joint trials on cervical cancer vaccine 22 December 2005 Merck antifungal drug faces key U.S. panel test 16 February 2001  search domain-b    go
Legal Policy | Copyright © 1999-2008 The Information Company Private Limited. All rights reserved.